SCHEMBL9047281

SCHEMBL9047281

N#C[C@@H]1CCCN1C(=O)[C@H]1NCC(=S)C1C(=O)CCc1cc2ccccc2o1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PREP P48147 1/20 0.44
DPP4 P27487 12/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9047415 0.91 PREP (0.48) PREPDPP4
SCHEMBL9049751 0.87 PREP (0.45) PREP
SCHEMBL9049551 0.87 PREP (0.45) PREP
SCHEMBL9049354 0.86 PREP (0.35) PREPDPP4
SCHEMBL9047286 0.85 PREP (0.46) PREPDPP4
SCHEMBL9049498 0.84 PREP (0.43) PREP
SCHEMBL9050599 0.84 PREP (0.42) PREP
SCHEMBL9050112 0.83 DPP4 (0.44) DPP4
SCHEMBL9046795 0.82 PREP (0.42) PREP
SCHEMBL9050770 0.82 PREP (0.42) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed